selected publications
- Acquisition of discrete immune suppressive barriers contributes to the initiation and progression of preinvasive to invasive human lung cancer. 2025 GET IT
-
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy.
Nature immunology.
2024
Academic Article
GET IT
Times cited: 2 - Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockade. 2023 GET IT
-
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer.
Nature communications.
2023
Academic Article
GET IT
Times cited: 18